Ads
related to: narcolepsy in humans- Cataplexy in Narcolepsy
Gain more insights into the signs
and symptoms of cataplexy.
- Diagnosis Resources
View diagnostic criteria for
narcolepsy and find ICD-10 codes.
- EDS and Narcolepsy
Excessive daytime sleepiness
is more than just falling asleep.
- Regulating Wakefulness
Discover the role of wake-promoting
neurons in sleep-wake cycle.
- Clinical Assessment
See clinical interview strategies
for identifying ongoing symptoms.
- Narcolepsy Neurobiology
Sleep-wake state stability, role of
the hypothalamus and histamine.
- Cataplexy in Narcolepsy
Search results
Results From The WOW.Com Content Network
Narcolepsy is a chronic neurological disorder that impairs the ability to regulate sleep–wake cycles, and specifically impacts REM (rapid eye movement) sleep. [1] The pentad symptoms of narcolepsy include excessive daytime sleepiness (EDS), sleep-related hallucinations, sleep paralysis, disturbed nocturnal sleep (DNS), and cataplexy. [1]
Orexin (/ ɒ ˈ r ɛ k s ɪ n /), also known as hypocretin, is a neuropeptide that regulates arousal, wakefulness, and appetite. [5] It exists in the forms of orexin-A and orexin-B.The most common form of narcolepsy, type 1, in which the individual experiences brief losses of muscle tone ("drop attacks" or cataplexy), is caused by a lack of orexin in the brain due to destruction of the cells ...
Pediatric narcolepsy cases are cases when patients are diagnosed or experience symptoms onset for narcolepsy before the age of 18. Of patients who obtain a formal diagnosis for narcolepsy, more than 50% report first experiencing symptoms of narcolepsy more than 10 years before their formal diagnosis, with an average age of symptom onset being at age 15 and symptom onset most likely to occur ...
Treatment for narcolepsy and cataplexy can be divided to those that act on the excessive daytime sleepiness (EDS) and those that improve cataplexy. Most patients require lifelong use of medications. [15] Most treatments in humans will act only symptomatically and do not target the loss of the orexin-producing neurons. [16]
Thomas S. Kilduff is an American neuroscientist and the director of SRI International's Center for Neuroscience. He specializes in neurobiology related to sleep and wakefulness, and was involved in the discovery of hypocretin (also known as orexin), [1] [2] a neuropeptide system that is highly involved in wakefulness regulation.
Sodium oxybate, sold under the brand name Xyrem among others, is a medication used to treat symptoms of narcolepsy: sudden muscle weakness and excessive daytime sleepiness. [3] [7] [8] It is used sometimes in France and Italy as an anesthetic given intravenously.
Ads
related to: narcolepsy in humans